Mar Vista Animal Medical Center

3850 Grand View Blvd.
Los Angeles, CA 90066




(for veterinary information only)




7.5 & 15 mg TABLETS



Meloxicam is a member of the class of drugs known as NSAIDs (non-steroidal anti-inflammatory drugs), the same class as such common human over-the-counter remedies as Advil (Ibuprofen), Aleve (Naproxen), and Aspirin as well as more controversial human prescription drugs such as Celebrex (celecoxib) and Vioxx (rofecoxib). Virtually everyone in the U.S. is familiar with at least some of these. This class of drug is used for pain relief successfully in humans but the development of safe NSAIDs for dogs has only been achieved relatively recently and continues to be problematic in the cat. With the possible exception of aspirin, none of the human drugs listed above can be safely used in pets and even aspirin has its issues.

While most humans are quite tolerant of NSAIDs, dogs and cats are more sensitive. The issues of concern that have prevented human NSAID use in pets are:

  • Stomach ulceration - even perforation and rupture of the stomach can occur. This is not only painful but life-threatening.
  • Platelet deactivation - platelets are the cells controlling the ability to clot blood and, as a general rule, it is preferable not to promote bleeding. We would prefer platelets to remain active and able to function should we need them.
  • Decreased blood supply to the kidney - this could tip a borderline patient in to kidney failure.


The veterinary profession had been in need of an NSAID that could effectively relieve pain without the above risks. Meloxicam is a human NSAID which turns out to offer important safety aspects to both dogs and cats.

What made the new plane of safety possible was the development of COX-preferential NSAIDs. COX stands for Cyclo-oxygenase and represents the enzyme that must be suppressed in order to suppress inflammation and pain. The problem is that COX does more than create pain and inflammation; it also helps maintain kidney and GI circulation as well as platelet function. Traditional NSAIDs (aspirin etc.) suppress COX in all forms but newer technology has made it possible to preferentially suppress only the inflammatory COX. COX-1 is considered the "good COX" and "COX-2" is considered the inflammatory COX. This has not only been helpful for people but, since pets are more sensitive, it has opened the door to numerous animal medications.

Meloxicam was already available for human use but human doses were way too high to be safe for most small animals. With understanding of the COX system, oral liquids which can be precisely dosed for pets are now available.



Meloxicam is generally given to control arthritis pain in dogs though it can be given for many other painful conditions such as injuries, cancer, surgery, dental infections, and more. In dogs, it is typically given as a once a day as a pleasantly flavored liquid. The veterinary approved product comes with a special dosing syringe marked to show how much to give for the pet's weight (rather than in milliliters as most syringes are marked).

Feline use of meloxicam is of some controversy. In Europe, Canada, Australia and New Zealand, long term use of the 0.5 mg/ml meloxicam formula in cats is registered, approved, and heavily marketed; however, this formula is not legally approved for cats in the United States. Further, the manufacturer has specifically discouraged feline use of meloxicam beyond its approved use in the U.S. (one dose for post surgical pain relief). This paradox of marketing the product one way for most of the world and another way in the U.S. has been frustrating as there are substantially fewer oral pain relief options for cats available compared to what is available for dogs. Meloxicam is still used by many veterinarians for cats but the advent of robenacoxib has provided a less controversial feline NSAID. Further, there are other medications and supplements for feline pain relief that can be combined into a less controversial regimen.

If a dose is skipped, do not double up on the next dose. Give the dose when it is remembered and schedule the next dose accordingly. Store this product at room temperature.



Stomach upset: vomiting, diarrhea, and/or appetite loss are the important side effects to watch for, especially in the three weeks or so after beginning long term meloxicam. These symptoms can have multiple meanings so it is important to sort them out.

  • Some pets are simply sensitive to NSAIDs, despite the COX-preferential nature of carprofen described above. These pets simply need nausea relief in the short term and a different pain management regimen after recovery.

  • Some dogs have an unrecognized liver problem. Meloxicam is removed from the body by the liver which means that the liver on meloxicam has extra work. This is not a problem for a normal liver but a diseased liver could be tipped into failure from the extra load. This is why screening tests are so important prior to long term use.

  • Another problem manifesting with upset stomach is an idiosyncratic hepatopathy (a liver condition that is not dose-dependent or predictable in any way). While this only occurs in 1 in 5000 dogs, it is a more serious problem which likely would require hospitalization.

  • Altered kidney function (especially in cats) is a concern with any NSAID and might also manifest as an upset stomach. This is another reason why pre-screening of kidney function before long term use is especially important before beginning meloxicam.

If a pet on meloxicam develops an upset stomach, discontinue the medication and report the problem to your veterinarian. It is prudent to check liver enzymes and kidney function (a blood test) to rule out the two liver side effect issues and kidney issues described that could manifest with upset stomach.

Other side effects typically require other pre-existing conditions that could be made worse by giving an NSAID (even a COX-preferential one). See the Concerns and Cautions section.


Drugs of the NSAID class should not be used concurrently as the potential for the aforementioned side effects increases. For similar reasons, NSAIDS should not be used in conjunction with corticosteroid hormones such as prednisone, dexamethasone, etc. A 5 to 7 day rest period is recommended when changing from one NSAID to anotherAspirin poses an exception due to its strong platelet inactivating abilities so 10 to 14 days is recommended when switching to another veterinary NSAID from aspirin. Allow at least one week between prednisone and meloxicam.

ACE inhibitors such as enalapril, or benazepril may not be as effective in the presence of meloxicam. (ACE inhibitors are used in the treatment of hypertension or heart failure.) This is because ACE inhibitors depend on the dilation of blood vessels in the kidneys and such dilation can be interfered with by NSAIDs).

Sulfa class antibiotics can slow the removal of meloxicam from the body thus increasing the possibility of meloxicam toxicity.

The risk for bleeding can be increased by combining meloxicam with pentoxifylline or with SSRI antianxiety medications such as fluoxetine.



  • Meloxicam works best when given with food. Should not be squirted directly in the mouth of smaller patients (under 10 lbs) if possible (best mixed in food). Shake bottle before using.

  • Maximum effect is seen approximately 8 hours after administration. When beginning a trial course of meloxicam, a response may take 3 or 4 days to show. If no response has been seen in 10 days, meloxicam has failed and a different pain medication should be tried. If one NSAID fails, another may well work.

  • The veterinary formulations of meloxicam are oral liquids (either 1.5mg/ml or 0.5 mg/ml). The liquid formulation allows for accuracy in dosing. The human tablets are available in much higher strengths and will be inappropriate except possibly for very large dogs. It is important not to use human medications on pets unless your veterinarian has provided detailed dosing instructions.

  • Meloxicam should not be used in pregnancy or in lactation.

  • Expect monitoring tests to be periodically needed when this medication is used long term.

  • Meloxicam should be avoided, if possible, in patients with impaired function of the liver, kidney or heart. It should also be avoided in dehydrated patients and patients with known GI ulcers.




The Food and Drug Administration's page on veterinary non-steroidal anti-inflammatory drugs may be viewed at:


Printer Friendly Version


Page last updated: 1/2/2020